Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Tacrolimus in Breast Cancer-related Lymphedema
NCT06306274Phase 3Enrolling by invitation
- Sponsor
- University Hospital Odense
- Start
- Sep 2024
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Tacrolimus Ointment 0.1% Iwaki in breast cancer-related lymphedema (BCRL), sponsored by University Hospital Odense. Started Sep 2024; status: enrolling by invitation.
02
Drugs
Tacrolimus Ointment 0.1% Iwaki
03
Conditions
breast cancer-related lymphedema (BCRL)
Beyond the preview
Go deeper on NCT06306274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06306274.